RecruitingNCT06506578

Nausea Induced by Radiation of the Dorsal Vagal Complex for Benign Brain Tumors (NausiCAA)

Characterization of Nausea Induced by Radiation of the Dorsal Vagal Complex in the Context of Benign Brain Tumors (NausiCAA)


Sponsor

University Hospital, Bordeaux

Enrollment

100 participants

Start Date

May 20, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Patients irradiated to the brain frequently experience nausea. The dorsal vagal complex (DVC) area is a specific brainstem zone and has been identified as likely responsible for nausea. Existing clinical studies show correlation between dose to the DVC and nausea, but they concern tumors of the airways and upper digestive tract, where there are many confounding factors. The aim of this study is to establish a ling between radiation dose to the DVC and nausea. Defining a dose threshold to the DVC will allow radiation oncologists to optimize radiation dose distribution and reduce nausea in patients.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • More than 18 years old
  • With benign brain tumor
  • Irradiated with conventional fractionation (1,8-2Gy/fraction)

Exclusion Criteria6

  • History of brain radiation
  • History of head and neck radiation
  • Demencia
  • Concurrent chemotherapy
  • Nausea at the time of inclusion
  • Anti-nausea treatment : corticosteroids, metoclopramide, setrons, other

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONRadiation

Radiation


Locations(3)

CHU de Bordeaux, Service de Radiothérapie

Bordeaux, France

Hospices Civils de Lyon, Service d'Oncologie Radiothérapie - Hôpital Neurologique

Lyon, France

Institut de cancérologie Strasbourg Europe (ICANS), Service d'Oncologie Radiothérapie

Strasbourg, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06506578